Alamar Biosciences

Exhibitor Plus

Information

Alamar Biosciences Bio : Alamar Biosciences is unlocking the future of neurological diagnostics with high-sensitivity and multiplex protein detection in biofluid samples. The NULISAseq™ CNS Disease Panel 120 provides multiplex analysis of biologically informed content with the highest sensitivity and broadest dynamic range. Analysis of 120+ proteins supports protein biomarker discovery and validation studies and includes biomarkers such as GFAP, UCH-L1 and alpha-synuclein. Complementing this, the NULISAseq™ Inflammation Panel contains ~250 important markers enabling comprehensive analysis of immune and inflammatory diseases. The NULISA immunoassays run on the innovative ARGO™ HT System, delivering a fully automated workflow and comprehensive multiplex data analysis in <16 hours.